Prescription Drug Transparency and Affordability Act
119-hr2450 — Prescription Drug Transparency and Affordability Act. Sponsored by Rep. McDonald Rivet, Kristen [D-MI-8]. Introduced 2025-03-27. House bill. 119th Congress. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Activity
House
Introduced in House
2025-03-27
Introduced
2025-03-27
Introduced in House
Referred to Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee
2025-03-27
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsor
- Rep. McDonald Rivet, Kristen [D-MI-8] (D), MI
- Introduced
- 2025-03-27
- Committees
- Ways and Means Committee; Education and Workforce Committee; Energy and Commerce Committee
- Latest Action
- Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
No roll-call vote data available for this bill.
Explore This Bill
Investigate this bill → AI summary, roll-call breakdown, and full bill analysis